HeartWare to float new shares
Thursday, 05 June, 2008
HeartWare (ASX: HTW) will hold an extraordinary general meeting next month to receive shareholder permission to float up to 70 million new shares.
The shares will be offered privately to professional investors in Australia and the US, and will be sold at $0.50 cents a share.
The purpose of the listing is to raise $30 million in capital. HeartWare, which manufactures miniature medical devices, will offer a share purchase plan to allow current stockholders the opportunity to purchase the new shares at the same price as that offered to the private investors.
Babies of stressed mothers likely to get their teeth earlier
Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...
Customised immune cells used to fight brain cancer
Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...
Elevated blood protein levels predict mortality
Proteins that play key roles in the development of diseases such as cancer and inflammation may...
